AI assistant
Organon & Co. — Director's Dealing 2025
Feb 24, 2025
31461_dirs_2025-02-24_5328666e-9abd-4e28-bc6e-c32a0e95af13.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Organon & Co. (OGN)
CIK: 0001821825
Period of Report: 2025-02-20
Reporting Person: Morrissey Joseph T. Jr. (Head of Manufacturing)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2025-02-20 | Common Stock | A | 15441 | — | Acquired | 58309 | Direct |
| 2025-02-20 | Common Stock | F | 4703 | $14.92 | Disposed | 53606 | Direct |
| 2025-02-20 | Common Stock | A | 2828 | — | Acquired | 56434 | Direct |
| 2025-02-20 | Common Stock | F | 806 | $15.29 | Disposed | 59423.855 | Direct |
Footnotes
F1: Represents shares of Organon & Co. common stock ("Common Stock") for performance share units ("PSUs") granted to the reporting person on August 09, 2022 under the Organon & Co. 2021 Incentive Stock Plan. The performance-vesting restrictions with respect to these shares were released upon certification of performance goal attainment by the Talent Committee of Organon's Board of Directors.
F2: Represents the shares of Common Stock released to cover the dividend equivalents earned on the PSUs released above.
F3: Includes the addition of 3,795.855 shares of Common Stock acquired from dividend reinvestments not previously reported.